HomeRVNC • NASDAQ
add
Revance Therapeutics Inc
Previous close
$2.84
Day range
$2.88 - $3.17
Year range
$2.59 - $32.45
Market cap
314.39M USD
Avg Volume
2.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 51.94M | 13.46% |
Operating expense | 69.46M | 11.20% |
Net income | -53.15M | 11.11% |
Net profit margin | -102.34 | 21.66% |
Earnings per share | -0.54 | 27.03% |
EBITDA | -44.85M | -11.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 277.07M | 1.14% |
Total assets | 508.12M | -7.24% |
Total liabilities | 606.79M | 5.63% |
Total equity | -98.67M | — |
Shares outstanding | 104.45M | — |
Price to book | -2.99 | — |
Return on assets | -23.73% | — |
Return on capital | -33.26% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -53.15M | 11.11% |
Cash from operations | -65.94M | 5.12% |
Cash from investing | -31.71M | -133.27% |
Cash from financing | 92.83M | 2,743.12% |
Net change in cash | -4.82M | -116.57% |
Free cash flow | -51.79M | -18.83% |
About
Founded
1999
Headquarters
Website
Employees
597